Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
02/14/2001 | EP1075475A1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production |
02/14/2001 | EP1075471A1 Indolyl derivatives as serotonergic agents |
02/14/2001 | EP1075467A1 Pyrazole derivatives as p-38 map kinase inhibitors |
02/14/2001 | EP1075466A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
02/14/2001 | EP1075262A1 Desmethylpantoprazole compositions and methods |
02/14/2001 | EP0842170B1 Diphenylmethylene piperidine derivatives |
02/14/2001 | EP0836593B1 5-pyrazolylbenzoic acid derivatives as herbicides |
02/14/2001 | EP0828714B1 Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form |
02/14/2001 | EP0815120B1 17-difluoromethylene-oestratrienes |
02/14/2001 | EP0714897B1 Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity |
02/14/2001 | CN1284074A Novel compounds |
02/14/2001 | CN1284068A Substituted phenyl uracils |
02/14/2001 | CN1284066A Substituted inidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors |
02/14/2001 | CN1284064A 2,3-substituted indole compounds as cox-2 inhibitors |
02/14/2001 | CN1283995A Antiviral compounds |
02/14/2001 | CN1283623A 1,2,4,5-tetrahydro-benzo[d] azepine compound |
02/14/2001 | CN1283617A Terazololine-one |
02/14/2001 | CN1283615A New Process and intermediate |
02/14/2001 | CN1061977C Aryl substituted heterocycles |
02/13/2001 | US6187925 Intermediates and process for the synthesis of azasteroids |
02/13/2001 | US6187806 N-linked sulfone of heterocyclic thioester hair growth compositions and uses |
02/13/2001 | US6187796 Alopecia treatment; immunophilin affinity |
02/13/2001 | US6187795 Methods and compositions for treating allergic disorders and other disorders using norastemizole in combination with other active ingredients |
02/13/2001 | US6187794 Administering as antiasthmatic agent; side effect reduction |
02/13/2001 | US6187792 Compounds with analgesic effect |
02/13/2001 | US6187786 Antitumor and anticarcinogenic agents |
02/13/2001 | US6187784 Pipecolic acid derivative hair growth compositions and uses |
02/13/2001 | US6187781 Corticotropin releasing factor receptor antagonists; alzheimer*s, huntington, and parkinson disease; antidepressants, anxiolytic agents |
02/13/2001 | US6187776 Heterocyclic compounds and their use |
02/13/2001 | US6187774 Fused heterocyclic compounds and pharmaceutical applications thereof |
02/13/2001 | US6187773 1-(2-chloro-5-pyridylmethyl)-3,5-dimethyl-2-nitroiminohexa-hyd ro-1,3,5-triazine; nonphytotoxic |
02/13/2001 | US6187769 Benzoxazepine derivatives and their salts and medicaments containing the same |
02/13/2001 | US6187716 Heterocyclyluracil |
02/13/2001 | CA2203942C A pyrrolidylthiocarbapenem derivative |
02/13/2001 | CA2001203C Novel antimicrobial dithiocarbamoyl quinolones |
02/08/2001 | WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
02/08/2001 | WO2001009138A2 Chemokine receptor antagonists and methods of use therefor |
02/08/2001 | WO2001009137A1 Chemokine receptor antagonists and methods of use therefor |
02/08/2001 | WO2001009128A1 Thiourea and isothiourea derivatives for inhibiting ras-transformed cell growth |
02/08/2001 | WO2001009121A2 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
02/08/2001 | WO2001009120A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
02/08/2001 | WO2001009119A2 Chemokine receptor antagonists |
02/08/2001 | WO2001009106A1 Diamino-1,2,4-triazole-carboxylic and derivatives as gsk-3 inhibitors |
02/08/2001 | WO2001009104A1 Trifluoromethylpyri(mi)dine carboxamides |
02/08/2001 | WO2001009096A2 Potassium channel openers |
02/08/2001 | WO2001009094A2 Chemokine receptor antagonists and methods of use therefor |
02/08/2001 | WO2001008685A1 Acyclic and cyclic amine derivatives |
02/08/2001 | WO2001008684A1 Nicotine in therapeutic angiogenesis and vasculogenesis |
02/08/2001 | WO2000076984A3 Novel compounds, their use and preparation |
02/08/2001 | WO2000058295A3 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
02/08/2001 | CA2380644A1 2-pyrazolin-5-ones |
02/08/2001 | CA2380371A1 Thiourea and isothiourea derivatives for inhibiting ras-transformed cell growth |
02/08/2001 | CA2380032A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
02/08/2001 | CA2379993A1 Acyclic and cyclic amine derivatives |
02/08/2001 | CA2378936A1 Potassium channel openers |
02/07/2001 | EP1074545A1 Isoquinolinesulfonamide derivatives and drugs containing the same as the active ingredient |
02/07/2001 | EP1074543A1 Aminopiperidine derivatives as integrin alpha v beta 3 antagonists |
02/07/2001 | EP1074542A1 Sulfonamide-containing indole compounds |
02/07/2001 | EP1074256A2 Depolarizing skeletal muscle relaxants |
02/07/2001 | EP1073658A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
02/07/2001 | EP1073651A1 Indolyl derivatives as serotonergic agents |
02/07/2001 | EP1073642A1 The use of dihydropyrimidines as medicaments, and novel substances |
02/07/2001 | EP1073640A1 Naphthalene derivatives, their production and use |
02/07/2001 | EP1073638A1 Heterocyclically substituted amides, their production and their use |
02/07/2001 | EP1073637A1 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
02/07/2001 | EP1073635A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
02/07/2001 | EP1073438A1 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDENE)-5H-BENZO 5,6]CYCLOHEPTA 1,2-b]PYRIDINE ORAL COMPOSITIONS |
02/07/2001 | EP1073332A1 R-rabeprazole compositions and methods |
02/07/2001 | EP0922035B1 Tetrahydroisoquinoline derivatives and their pharmaceutical use |
02/07/2001 | EP0533882B1 2-quinolinone derivatives, methods for preparing the same and fungicides and insecticides including them |
02/07/2001 | CN1283192A Inhibition of raf kinase using aryl and hetroaryl substituted heterocyclic ureas |
02/07/2001 | CN1283191A Benzylidene pyrazolones and its preparation and use |
02/07/2001 | CN1283190A Substituted benzene compounds, process for their preparation and herbicidal and defoliant composition containing them |
02/07/2001 | CN1283189A Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
02/07/2001 | CN1283187A Novel dipydropyridine derivative |
02/07/2001 | CN1283186A Indole derivatives as XA factor inhibitors |
02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
02/07/2001 | CN1283181A Substituted beta-alanines |
02/07/2001 | CN1283180A Inhibition of raf kinase using symmerical and unsymmerical substituted diphenyl ureas |
02/07/2001 | CN1282517A Pest controlling agent containing substituted aminoquinazolone or thioketone derivative or its salt as active component |
02/07/2001 | CN1061657C Substituted thiophoene derivative and agricultural and horticultural fungicide containing the same as active ingredient |
02/07/2001 | CN1061654C Process for preparation of tetrazole derivatives |
02/07/2001 | CN1061651C Herbicidal 1-alkenyltetrazolinones |
02/07/2001 | CN1061650C 1-cycloalkenyltetrazolinones |
02/06/2001 | US6184243 Neurological disorders |
02/06/2001 | US6184242 2-(substituted-phenyl)amino-imidazoline derivatives |
02/06/2001 | US6184238 Antiallergens, antiinflammatory agents |
02/06/2001 | US6184237 Substituted pyridine compounds and methods of use |
02/06/2001 | US6184234 Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl or pyridyl)methyl]piperidines |
02/06/2001 | US6184229 For treatment of disorders associated with the disfunctioning of nicotinic receptors |
02/06/2001 | US6184226 Antiinflammatory agents for treatment of cardiovascular system disorders/respiratory system disorders, antiischemic agents |
02/06/2001 | US6184183 Heterocyclyluracils |
02/06/2001 | US6183878 Electrochromic system |
02/06/2001 | US6183776 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
02/06/2001 | CA2314798A1 1,2,4,5-tetrahydro-benzo[d]azepin derivatives |
02/06/2001 | CA2126118C 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative |
02/01/2001 | WO2001007643A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating the drug effect of antimicrobial agent, and antimicrobial agents |
02/01/2001 | WO2001007437A1 Crystal forms of 1-(3-chlorophenyl)-4-[1-(4-cyanobenzyl)-5-imidazolylmethyl]-2-piperazinone |
02/01/2001 | WO2001007436A2 Substituted oxoazaheterocyclyl compounds |